ARTICLE | Company News
Alkermes, Eli Lilly deal
April 9, 2001 7:00 AM UTC
ALKS and LLY will exclusively develop inhaled formulations of insulin using ALKS's AIR pulmonary drug delivery system. ALKS will receive development funding, milestone payments and royalties. LLY will...